Bioregenx (BRGX) Other Non-Current Liabilities (2021)
Bioregenx's (BRGX) quarterly Other Non-Current Liabilities came in at $60597.0 in Q4 2021.
Bioregenx (BRGX) Other Non-Current Liabilities (2021) Analysis & Trends
Bioregenx's Other Non-Current Liabilities history runs 1 years deep, the most recent figure standing at $60597.0 for Q4 2021.
- On a quarterly basis, Other Non-Current Liabilities changed N/A year-over-year to $60597.0 in Q4 2021; TTM through Dec 2021 was $60597.0, a N/A change from a year earlier, with the FY2021 full-year figure at $60597.0, changed N/A from the prior year.
- Other Non-Current Liabilities steadied at $60597.0 in Q4 2021 per BRGX's latest filing.
- Across five years, Other Non-Current Liabilities topped out at $60597.0 in Q4 2021 and bottomed at $60597.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 32.17 Bn | 24.85 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 14.60 Bn | 13.70 Bn | 482.22 Mn |
| 3 | Healthequity | 8.41 Bn | 8.14 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.96 Bn | 5.64 Bn | 154.23 Mn |
| 5 | 10x Genomics | 5.86 Bn | 5.32 Bn | 106.18 Mn |
| 6 | MiniMed | 4.51 Bn | 4.21 Bn | 480.00 Mn |
| 7 | Waystar Holding | 4.47 Bn | 4.40 Bn | 216.84 Mn |
| 8 | Doximity | 3.95 Bn | 3.21 Bn | 125.97 Mn |
| 9 | Privia Health | 3.12 Bn | 2.70 Bn | - |
| 10 | Bioregenx | 9.69 Mn | 9.65 Mn | 348,288.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 60,597.00 |